Diagnostic Yield of Reanalysis After Nondiagnostic Genome Sequencing in Infants With Unexplained Epilepsy
Dr. Halley Alexander and Dr. Alissa M. D'Gama discuss genetic testing for infantile epilepsies. Show citation: Nguyen JNH, Lachgar-Ruiz M, Higginbotham EJ, et al. Diagnostic Yield of Comprehensive…
Read the full articleYou might also wanna read
https://doi.org/10.1001/jamaneurol.2026.1021
A JAMA Neurology study finds X% of infants with genetic epilepsies may benefit from antisense oligonucleotide (ASO) therapy. PMID:42081236,
A Study of the Value of Trio Genome Sequencing in the Etiological Evaluation of Early-Onset and/or Atypical Psychiatric Disorders Without Intellectual Disability or Congenital Anomalies
Conditions : Genetic; Diagnostic Strategies Interventions : Biological: Blood sample Sponsors : Centre Hospitalier Universitaire Dijon Not y
An Open-Source Pipeline Re-Scanned Dormant Genomes — and Found 241 New Rare-Disease Diagnoses
Talos, an open-source automated genomic reanalysis pipeline, surfaced 241 new rare-disease diagnoses in 238 people from 4,735 undiagnosed pa
Reducing the Diagnostic Odyssey via Newborn Screening by Genome Sequencing
Traditional NBS uptake has been slow, now new technology is launching pilot projects in NBS by genome sequencing for hundreds of treatable d
Assessing Knowledge and Decision-Making in Basic Genomics among Adolescents and Adults
Background Genetic testing and genomic sequencing are increasingly part of pediatric care, yet many adolescents and parents lack the knowled
Boston Children's Hospital uses OpenAI's o3 model to diagnose rare genetic diseases in children
Researchers from Boston Children’s Hospital identified 18 diagnoses for children with rare diseases using OpenAI’s o3 model.
nbcnews.com·24d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.